The Management of Essential Thrombocythaemia.

Area of Science:

• Hematology
• Oncology
• Internal Medicine

Background:

• Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
• While often having a benign course, ET carries a significant risk of thromboembolic complications, particularly in older patients or those with prior thrombosis.
• Current therapeutic strategies aim to mitigate morbidity and mortality associated with ET.

Purpose of the Study:

• To review the current therapeutic options for essential thrombocythemia.
• To delineate treatment strategies based on patient age, history, and symptoms.
• To highlight the role of hydroxyurea and other agents in managing ET.

Main Methods:

• Review of existing clinical practice guidelines and therapeutic evidence for essential thrombocythemia.
• Analysis of treatment indications based on patient risk factors such as age, thrombosis history, and platelet count.
• Evaluation of the efficacy and safety profiles of cytoreductive agents (hydroxyurea, interferon, anagrelide) and antiplatelet drugs.

Main Results:

• Hydroxyurea is recommended for patients over 60, with a history of thrombosis or bleeding, or extremely high platelet counts (>1,000 X 10(9)/L).
• Hydroxyurea has demonstrated efficacy in reducing both platelet count and thromboembolic complications.
• Low-dose aspirin may be used adjunctively for thrombosis or microvascular disturbances. Observation or antiplatelet therapy is considered for younger, asymptomatic patients.
• Interferon or anagrelide are potential alternatives, particularly given concerns about hydroxyurea's risk of leukemia transformation.

Conclusions:

• Treatment decisions for essential thrombocythemia are individualized, considering patient-specific factors.
• Hydroxyurea is the current treatment of choice for high-risk ET patients due to its proven benefits in reducing thrombotic events.
• Further research into alternative therapies like interferon and anagrelide is warranted, especially concerning long-term safety and potential risks.